But personalized obesity care in the future might As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of obesity
Poh Journal: Journal of Oncology Journal ranking: Q2 Key takeaways: Peptide-based cancer vaccines show promise, but optimal antigen targets, adjuvants, and immunization regimens need to be optimized for clinical safety and effectiveness
Fang M, Jeon Y, Echouffo-Tcheugui JB, Selvin E (2023) Prevalence and management of obesity in U.S
A.del Olmo-AguadoS.OsborneN
2C and Additional file 1: Fig
The most common side effect associated with this highest dose was dysesthesia, an abnormal sensation in the nerves that can cause unexplained skin sensitivity, tingling or burning, in about 12% of patients